PPAR Agonists and Cardiovascular Disease in Diabetes
Peroxisome proliferators activated receptors (PPARs) are ligand-activated nuclear transcription factors that play important roles in lipid and glucose homeostasis. To the extent that PPAR agonists improve diabetic dyslipidaemia and insulin resistance, these agents have been considered to reduce card...
Saved in:
Main Authors: | Anna C. Calkin, Merlin C. Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/245410 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
by: Zhanjun Jia, et al.
Published: (2014-01-01) -
PPARγ and Its Agonists in Chronic Kidney Disease
by: Yuhua Ma, et al.
Published: (2020-01-01) -
Role of PPARα and Its Agonist in Renal Diseases
by: Ching-Feng Cheng, et al.
Published: (2010-01-01) -
PPAR Agonists for the Prevention and Treatment of Lung Cancer
by: Sowmya P. Lakshmi, et al.
Published: (2017-01-01) -
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
by: Anna R. Carta, et al.
Published: (2011-01-01)